- March 15, 2022
- Newsletter
- 617-430-5616
Menu
» Home » Drug Database » Anticoagulants » Vitamin K Antagonists » warfarin
ADVERTISEMENT
ADVERTISEMENT
» Home » Drug Database » Anticoagulants » Vitamin K Antagonists » warfarin
Brand Name :
Coumadin,Jantoven
Synonyms :
APO-Warfarin,TARO-Warfarin
Class :
Anti-coagulant, Vitamin K antagonist
No drug interaction found for warfarin and .
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K antagonists
may enhance the anticoagulant effect of Vitamin K antagonists
when both drugs are combined, there may be an increase in the anti-coagulant action
it enhances the effects of warfarin by anti-coagulation
may increase the metabolism of vitamin K antagonists
may increase the metabolism of vitamin K antagonists
may increase the metabolism of vitamin K antagonists
may increase the metabolism of vitamin K antagonists
may increase the metabolism of vitamin K antagonists
may increase the anti-coagulant effect of androgens
may increase the anti-coagulant effect of salicylates
may enhance the anticoagulant effect of fibric acid derivatives
may increase the anti-coaugulant effect of salicylates
may increase the anti-coagulant effect of nonsteroidal anti-inflammatory agents
may increase the therapeutic efficacy of warfarin when combined
may increase the CNS depressant effect of CNS depressants
they may diminish the serum concentration when combined with vitamin k antagonists
may enhance the serum concentration when combined with Vitamin K Antagonists
estrogens esterified/methyltestosterone
may increase the anticoagulant effect of Androgens
may increase the anticoagulant effect of Salicylates
may enhance the serum concentration of Antacids
aluminum hydroxide/magnesium carbonate
may enhance the serum concentration of aluminum hydroxide
It may enhance the serum concentration when combined with miconazole (topical)
methyltestosterone increases the anticoagulatory effect of warfarin
it decreases the rate of elimination of pidotimod
Interaction decreases the therapeutic effects of warfarin.
pentamycin increases the therapeutic efficacy of warfarin when used in combination
bismuth subsalicylate increases the anticoagulatory effect of warfarin
oxymetholone by anticoagulation increases the effect of warfarin
danazol increases the anticoagulatory effect of warfarin
fluoxymesterone increases the anticoagulatory effect of warfarin
methyltestosterone increases the anticoagulatory effect of warfarin
oxandrolone increases the anticoagulatory effect of warfarin
oxandrolone increases the anticoagulatory effect of warfarin
methyltestosterone increases the anticoagulatory effect of warfarin
allopurinol enhances the effects of warfarin by anti-coagulation
betrixaban enhances the anti-coagulant effects of warfarin
may enhance the toxicity of the other through anti coagulation
may diminish the serum concentration
may increase the risk or severity of gastrointestinal bleeding when combined
allopurinol increases the effect of anticoagulation of vitamin K antagonists
may increase the anticoagulant effect of each other when combined
methyltestosterone increases the anticoagulatory effect of warfarin
penicillins may iincrease the anticoagulant effect of Vitamin K Antagonists
penicillins may iincrease the anticoagulant effect of Vitamin K Antagonists
penicillins may iincrease the anticoagulant effect of Vitamin K Antagonists
penicillins may iincrease the anticoagulant effect of Vitamin K Antagonists
penicillins may iincrease the anticoagulant effect of Vitamin K Antagonists
quinolones may enhance the anticoagulant effect of Vitamin K antagonists
quinolones may enhance the anticoagulant effect of Vitamin K antagonists
Selective Serotonin Reuptake Inhibitors may enhance the anticoagulant effect of Vitamin K
Selective Serotonin Reuptake Inhibitors may enhance the anticoagulant effect of Vitamin K
Selective Serotonin Reuptake Inhibitors may enhance the anticoagulant effect of Vitamin K
Selective Serotonin Reuptake Inhibitors may enhance the anticoagulant effect of Vitamin K
Selective Serotonin Reuptake Inhibitors may enhance the anticoagulant effect of Vitamin K
may increase the anticoagulant effect when combined with vitamin k antagonists
may increase the anticoagulant effect of vitamin K antagonist
may increase the anticoagulant effect of vitamin K antagonist
may increase the anticoagulant effect of vitamin K antagonist
may increase the anticoagulant effect of vitamin K antagonist
may increase the anticoagulant effect of vitamin K antagonist
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
choline magnesium trisalicylate
It may increase the anticoagulant effect when combined with Salicylates (Topical)
It may enhance the serum concentration when combined with CYP2C9 Inhibitors
It may enhance the serum concentration when combined with CYP2C9 Inhibitors
thyroid products increase the effect of anticoagulation of vitamin K antagonists
thyroid products increase the effect of anticoagulation of vitamin K antagonists
thyroid products increase the effect of anticoagulation of vitamin K antagonists
thyroid products increase the effect of anticoagulation of vitamin K antagonists
The miconazole (oral) has the potential to elevate the levels of warfarin in the bloodstream
It may enhance the effects when combined with triamcinolone by unspecified mechanisms interaction
it may diminish the excretion rate when combined with antibiotics, resulting in an enhanced serum level
Vitamin K antagonists: they may increase the antiplatelet effect of antiplatelet agents
Vitamin K antagonists: they may increase the antiplatelet effect of antiplatelet agents
Vitamin K antagonists: they may increase the antiplatelet effect of antiplatelet agents
Vitamin K antagonists: they may increase the antiplatelet effect of antiplatelet agents
Vitamin K antagonists: they may increase the antiplatelet effect of antiplatelet agents
nafcillin will decrease the effect of action of warfarin by affecting enzyme CYP3A4 metabolism.
piperacillin increases the effectiveness of warfarin by synergism
When bacampicillin combines with warfarin, there may be increased risk of bleeding in liver and hepatic impairment and mostly in elderly patients.
When penicillin G benzathine combines with warfarin, the increased risk of bleeding is seen in renal or liver impairment and elderly patients.
when both drugs are combined, there may be a decreased level of serum concentration of warfarin
may increase the serum concentration of warfarin
decreases effects of warfarin
the effect of warfarin is decreased by lorlatinib, by altering intestinal or hepatic CYP3A4 enzyme metabolism
gemcitabine, by an unspecific mechanism of interaction, increases the effect of warfarin
the level or effect of warfarin is increased by fluorouracil, by impacting CYP2C9/10 hepatic enzyme metabolism
when both drugs are combined, there may be an increased effect of warfarin by unspecified interaction mechanism
cefprozil increases the anticoagulant activity of warfarin by an unknown mechanism
cefaclor increases the anticoagulant activity of warfarin by an unknown mechanism
when both drugs are combined, there may be an increased risk of adverse effects
when both drugs are combined, there may be an increased risk or severity of adverse effects
cefepime increases the anticoagulant activity of warfarin by an unknown mechanism
When both drugs are combined, there may be an increased risk of adverse effects
cefuroxime increases the anticoagulant activity of warfarin by an unknown mechanism
demeclocycline enhances the therapeutic effects of warfarin
doxycycline enhances the therapeutic effects of warfarin
gefitinib, with the help of an unspecified interaction mechanism, increases the effect of warfarin
idelalisib increases the effect or level of warfarin by altering the intestinal/hepatic CYP3A4 metabolism
sorafenib increases the effect of anticoagulation in warfarin
capreomycin may enhance the anticoagulant effects of warfarin
Coadministration of Zidovudine with warfarin can increase the risk of bleeding or unusual bleeding
Coadministration of Tenofovir alafenamide with warfarin can increase the risk of bleeding or unusual bleeding
lansoprazole amoxicillin and clarithromycin
when amoxicillin combines with warfarin it decreases the effects of the action of drug by increasing bleeding and results in renal and liver impairment
amoxicillin and clavulanate potassium
when amoxicillin combines with warfarin it decreases the effects of the action of drug by increasing bleeding and results in renal and liver impairment
omeprazole amoxicillin and clarithromycin
when amoxicillin combines with warfarin it decreases the effects of the action of the drug by increasing bleeding and results in renal and liver impairment
when amoxicillin combines with warfarin it decreases the effects of the action of the drug by increasing bleeding and results in renal and liver impairment
Coadministration of tipranavir with warfarin can increase the risk of bleeding or unusual bleeding
may increase the metabolism of Vitamin K Antagonists
may increase the metabolism of Vitamin K Antagonists
may increase the metabolism of Vitamin K Antagonists
may increase the metabolism of Vitamin K Antagonists
may increase the metabolism of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may diminish the anticoagulant effect of Vitamin K Antagonists
may diminish the anticoagulant effect of Vitamin K Antagonists
may diminish the anticoagulant effect of Vitamin K Antagonists
may diminish the anticoagulant effect of Vitamin K Antagonists
may diminish the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may increase the serum concentration of Vitamin K Antagonists
may increase the serum concentration of Vitamin K Antagonists
may increase the serum concentration of Vitamin K Antagonists
may increase the serum concentration of Vitamin K Antagonists
may increase the serum concentration of Vitamin K Antagonists
may increase the serum concentration of Vitamin K Antagonists
may increase the serum concentration of Vitamin K Antagonists
may increase the serum concentration of Vitamin K Antagonists
may increase the serum concentration of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
l-methylfolate-pyridoxal 5′-phosphate-methylcobalamine
may enhance the anticoagulant effect of Vitamin K Antagonists
choline magnesium trisalicylate
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K antagonists
may enhance the anticoagulant effect of Vitamin K antagonists
may enhance the anticoagulant effect of Vitamin K antagonists
may enhance the anticoagulant effect of Vitamin K antagonists
may enhance the anticoagulant effect of Vitamin K antagonists
may diminish the anticoagulant effect of Vitamin K Antagonists
May may increase the anti-coagulant action when combined.
May increase the anti-coagulant action when combined.
may increase the serum concentration when both drugs are combined
May increase the anti-coagulant action when combined.
May increase the anti-coagulant action when combined
May increase the anti-coagulant action when combined
May increase the serum concentration when both drugs are combined
May increase the anti-coagulant action when combined
This may increase the anti-coagulant action when combined
May increase the anti-coagulant action when combined
May increase the anti-coagulant action when combined
This may increase the serum concentration when both drugs are combined
May increase the anti-coagulant action when combined
May increase the anti-coagulant action when combined
cephalosporins increase the effect of anticoagulation of vitamin K antagonists
cephalosporins increase the effect of anticoagulation of vitamin K antagonists
cephalosporins increase the effect of anticoagulation of vitamin K antagonists
cephalosporins increase the effect of anticoagulation of vitamin K antagonists
cephalosporins increase the effect of anticoagulation of vitamin K antagonists
vitamin K1 (phytonadione) may reduce the anticoagulant effect of vitamin K antagonists
cephalosporins may enhance the anticoagulant effect of vitamin K antagonists
cephalosporins may enhance the anticoagulant effect of vitamin K antagonists
cephalosporins may enhance the anticoagulant effect of vitamin K antagonists
metformin reduces the effect of anticoagulation of vitamin K antagonists
may increase the anticoagulant effect
may increase the anti-coagulant action of anti-coagulants
may increase the anticoagulant effect
may enhance the anticoagulant effect of Vitamin K antagonists
may enhance the anticoagulant effect of Vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may increase the effect of vitamin K antagonists
may decrease the anticoagulant effect of direct-acting viral agents
may decrease the anticoagulant effect of direct-acting antiviral agents
may increase the anticoagulant effect of cephalosporins
may increase the anticoagulant effect of cephalosporins
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
relugolix/estradiol/norethindrone
may increase the anticoagulant effect
relugolix/estradiol/norethindrone
may increase the anticoagulant effect
may increase the anticoagulant effect
may increase the anticoagulant effect
may increase the anticoagulant effect
may increase the anticoagulant effect of vitamin K antagonists
may increase the levels of serum concentration of vitamin K antagonists
may increase the levels of serum concentration of vitamin K antagonists
may increase the levels of serum concentration of vitamin K antagonists
may increase the levels of serum concentration of vitamin K antagonists
may increase the anticoagulant effect
may increase the anticoagulant effect
may increase the anticoagulant effect
May decrease the serum concentration
May decrease the serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the anticoagulant effect
amoxicillin and clavulanate potassium
may increase the anticoagulant effect
may increase the anticoagulant effect
may increase the anticoagulant effect
may increase the anticoagulant effect
may enhance the anticoagulant effect
may enhance the anticoagulant effect
may enhance the anticoagulant effect
may enhance the anticoagulant effect
may enhance the anticoagulant effect
may enhance the anticoagulant effect
may enhance the anticoagulant effect
bismuth subcitrate, metronidazole and tetracycline
ay enhance the anticoagulant effect
ay enhance the anticoagulant effect
ay enhance the anticoagulant effect
ay enhance the anticoagulant effect
ay enhance the anticoagulant effect
ay enhance the anticoagulant effect
ay enhance the anticoagulant effect
ay enhance the anticoagulant effect
may have an increased anticoagulant effect when combined with vitamin k antagonists
may increase the anticoagulant effect of HMG-CoA Reductase Inhibitors
drospirenone/ethinyl estradiol/levomefolate
may enhance the serum concentration of Hormonal Contraceptives
may increase the anticoagulant effect of Cephalosporins
may increase the anticoagulant effect of Cephalosporins
may increase the anticoagulant effect
may increase the anticoagulant effect
may increase the anticoagulant effect
may increase the anticoagulant effect
may decrease the anticoagulant effect of Vitamin K Antagonists
5-Aminosalicylic Acid Derivatives: they may increase the anticoagulant effect of Vitamin K Antagonists
5-Aminosalicylic Acid Derivatives: they may increase the anticoagulant effect of Vitamin K Antagonists
may decrease the anticoagulant effect of Direct Acting Antiviral Agents
may enhance the serum concentration of Hormonal Contraceptives
etonogestrel/ethinyl estradiol
may increase the serum concentration of Hormonal Contraceptives
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
oxaceprol decreases the effect of vitamin K antagonists
relugolix/estradiol/norethindrone
androgens increase the effect of anticoagulation of vitamin K antagonists like warfarin
relugolix/estradiol/norethindrone
androgens increase the effect of anticoagulation of vitamin K antagonists like warfarin
androgens increase the effect of anticoagulation of vitamin K antagonists like warfarin
androgens increase the effect of anticoagulation of vitamin K antagonists like warfarin
androgens increase the effect of anticoagulation of vitamin K antagonists like warfarin
androgens increase the effect of anticoagulation of vitamin K antagonists like warfarin
fibric acid derivatives increase the effect of anticoagulation of vitamin K antagonists
fibric acid derivatives increase the effect of anticoagulation of vitamin K antagonists
fibric acid derivatives increase the effect of anticoagulation of vitamin K antagonists
fibric acid derivatives increase the effect of anticoagulation of vitamin K antagonists
fibric acid derivatives increase the effect of anticoagulation of vitamin K antagonists
androgens increase the effect of anticoagulation of vitamin K antagonists like warfarin
Dosage Forms & Strengths
Powder for injection-5mg per vial
Tablet form:1,2,2.5,3,4,5,6,7.5,10 mg
Initial dose:
2 - 5
mg
oral/IV
every 48 hours
or 10mg oral for 2 days.
Check INR and adjust the dose.
Maintenance-2-10mg/day
Dose Adjustments
Dosing adjustment:
Hepatic impairment: defective synthesis of clotting factors and low metabolism
Kidney impairment: No data available.
Powder for injection-5mg per vial
Tablet form:1,2,2.5,3,4,5,6,7.5,10 mg
Refer adult dosing
Adverse effects
Frequency defined:
1-10%
Cholesterol embolism syndrome
Calciphylaxis
Hemorrhage
<1%
Dermatitis
Vasculitis
Hepatitis
Alopecia
Avoid neonates and infants less than 4 months old due to a higher risk of bleeding.
Pregnancy consideration: Category X (US FDA)
Lactation: The presence of the drug in human breast milk is unknown.
Pregnancy category:
Patient information leaflet
Generic Name: Warfarin (Rx)
Pronounced: [WAR-far-in]
Why do we use warfarin?
Warfarin belongs to the class of anti-coagulant. It is used to reduce the formation of blood clots in veins and arteries, thereby reducing the risk of heart attack or stroke.
ADVERTISEMENT
» Home » Drug Database » Anticoagulants » Vitamin K Antagonists » warfarin
Brand Name :
Coumadin,Jantoven
Synonyms :
APO-Warfarin,TARO-Warfarin
Class :
Anti-coagulant, Vitamin K antagonist
Dosage Forms & Strengths
Powder for injection-5mg per vial
Tablet form:1,2,2.5,3,4,5,6,7.5,10 mg
Initial dose:
2 - 5
mg
oral/IV
every 48 hours
or 10mg oral for 2 days.
Check INR and adjust the dose.
Maintenance-2-10mg/day
Dose Adjustments
Dosing adjustment:
Hepatic impairment: defective synthesis of clotting factors and low metabolism
Kidney impairment: No data available.
Powder for injection-5mg per vial
Tablet form:1,2,2.5,3,4,5,6,7.5,10 mg
Refer adult dosing